Acadian Asset Management LLC Vascular Biogenics Ltd. Transaction History

Acadian Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.11 - $0.16 $32,122 - $46,723	-292,020 Reduced 51.03%	280,191 $33,000
Q3 2022 Nov 14, 2022	BUY	$0.15 - $2.1 $85,831 - $1.2 Million	572,211 New	572,211 $88,000
Q2 2020 Aug 12, 2020	SELL	$1.12 - $1.63 $15,333 - $22,316	-13,691 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$0.96 - $1.57 $13,143 - $21,494	13,691 New	13,691 $18,000
Q3 2019 Nov 07, 2019	SELL	$1.11 - $1.42 $4,502 - $5,759	-4,056 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$1.16 - $1.53 $64,230 - $84,717	-55,371 Reduced 93.17%	4,056 $5,000
Q1 2019 May 09, 2019	BUY	$0.94 - $1.75 $40,858 - $76,065	43,466 Added 272.33%	59,427 $90,000
Q4 2018 Feb 07, 2019	BUY	$0.6 - $1.72 $9,576 - $27,452	15,961 New	15,961 $15,000
Q2 2018 Jul 24, 2018	SELL	$2.05 - $3.0 $148,901 - $217,905	-72,635 Closed	0 $0
Q1 2018 Apr 12, 2018	BUY	$2.27 - $8.5 $164,881 - $617,397	72,635 New	72,635 $167,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.